Next Med
Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region
NEWS
MILenARI launches its official LinkedIn page
The MILenARI project announce the launch of its official LinkedIn page, a new communication channel designed to share project updates, milestones, and key achievements with a wide professional audience.
Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region
Bambino Gesù Children’s Hospital Leads MILenARI Clinical Trial Preparation for Academic CAR‑T Across the Mediterranean
Ospedale Pediatrico Bambino Gesù (OPBG) plays a pivotal role in the MILenARI project by coordinating the preparation of future international clinical studies.
Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region
The American University of Beirut, MILenARI partner, will establish one of the first academic CAR-T facilities in the Middle East
The American University of Beirut (AUB) joins MILenARI as a key partner driving the decentralisation of CAR‑T production across Mediterranean Partner Countries. AUB co‑leads the work package dedicated to the establishment, certification, and validation of CAR‑T manufacturing facilities.
Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region
King Hussein Cancer Center joins MILenARI to advance CAR‑T manufacturing in Jordan
The King Hussein Cancer Center (KHCC), the largest specialised cancer institution in the Middle East, plays a strategic role in the MILenARI consortium. With a highly active Bone Marrow Transplant Programme and newly built cell therapy facilities, KHCC is poised to become a regional hub for academic CAR‑T development.
Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region
Clínic-IDIBAPS: Leading the Mediterranean Expansion of Academic CAR-T Therapy in MILenARI project
As the leader of the MILenARI project, Clínic-IDIBAPS stands at the forefront of academic CAR‑T innovation. The Barcelona team developed the first academic CAR‑T therapy authorized, now being scaled for international deployment.
Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region
MILenARI: a European project to democratize access to CAR-T therapy in the Mediterranean
On Tuesday, November 18, the consortium of the European project MILenARI (Mediterranean International Lentivirus ARI) held its inaugural meeting online, with the participation of all partners and representatives of the Interreg NEXT MED program, which funds the project. The meeting was very fruitful and marked the start of an initiative with a clear mission: to make CAR-T therapy accessible to more patients in the Mediterranean basin. The project has a total funding of €2,498,88.15, 89% of which is covered by the European Union.
Scaling-up advanced lentiviral (LV) and CAR-T academic production across the Mediterranean region